Alto Neuroscience, Inc. (ANRO) Stock Overview
Explore Alto Neuroscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Alto Neuroscience, Inc. (ANRO)
Key Financials
Key Financials
Market Cap
978.1M
P/E Ratio
-11.15
EPS (TTM)
$-2.42
ROE
-0.47%
ANRO Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Alto Neuroscience, Inc. (NYSE: ANRO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Alto Neuroscience, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ANRO on the NYSE shows an RSI of 59.98, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $38.58 for the NYSE listing.
Key metrics behind Alto Neuroscience, Inc.'s NYSE-traded stock include a P/E ratio of -11.15 and a market capitalization of 978.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ANRO on the NYSE.